BW A256C
Palatrigine is a compound with angiotensin-converting enzyme inhibitory and beta-adrenergic receptor blocking properties[1][2].
Product Specifications
CAS Number
98410-36-7
UNSPSC
12352005
Target
Angiotensin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Cardiovascular Disease; Others
Assay Protocol
https://www.medchemexpress.com/bw-a256c.html
Smiles
NC1=NC(N(C(C)C)N=C1C2=CC=CC(Cl)=C2Cl)=N
Molecular Formula
C12H13Cl2N5
Molecular Weight
298.17
References & Citations
[1]Allan G, et al. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents[J]. British journal of pharmacology, 1986, 88 (2) : 333-343.|[2]Donoghue S, et al. Effects of BW A256C, a novel class 1 antiarrhythmic agent, on maximum rate of depolarisation of cardiac action potentials in vitro: frequency, use, and voltage dependence[J]. Journal of cardiovascular pharmacology, 1987, 9 (1) : 12-18.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
41275061 1.0 µg DNA
RPL27AP5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
MBS1470038 Inquire
Recombinant Salmonella typhi DNA-directed RNA polymerase subunit beta (rpoB), partial
Sign In for Pricing
View Details 